Ozempic’s Success Is Bad News for Rivals
Bloomberg Businessweek

Ozempic’s Success Is Bad News for Rivals

Oct 23, 2023
7:10
-(0)

About this episode

Bloomberg News Health Reporter Madison Muller discusses how the drug Ozempic could cut demand for big-money drugs targeting a wide range of maladies, even Alzheimer’s. Hosts: Carol Massar and Tim Stenovec. Producer: Paul Brennan. See omnystudio.com/listener for privacy information.

Comments

Rate this episode

Episode Details

Author
Bloomberg
Show Type
full
Audio Format
audio/mpeg

We use analytics

We use Umami, a privacy-friendly analytics tool, to understand how visitors use this site. No personal data is collected and no data leaves our EU servers. You can accept or decline below. Privacy Policy